US pharma giant Pfizer (NYSE: PFE) on Monday revealed that Dr Andrew Baum will join the company as chief strategy and innovation officer, executive vice president.

Philadelphia, USA-based Latus Bio, a biotech developing novel gene therapy candidates for disorders of the central nervous system (CNS), has announced its launch and an initial close of $54 million in ...

Privately-held Italian drugmaker Chiesi Farmaceutici announced a deal with USA-based Gossamer Bio (Nasdaq: GOSS) for a global collaboration and license agreement to develop and commercialize the ...

Philadelphia, USA-based Latus Bio, a biotech developing novel gene therapy candidates for disorders of the central nervous system (CNS), has announced its launch and an initial close of $54 million in ...

The Bilateral III, a third package of bilateral agreements between the European Union (EU) and Switzerland on participation in the Single Market, ensures unhindered access to the European internal ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has now approved Pfizer’s Oxbryta (voxelotor) to be recommended for use on the National Health Service NHS to ...

AstraZeneca on Monday announced the successful completion of an equity investment with France-based Cellectis, a clinical-stage biotechnology company.

The prestigious New England Journal of Medicine (NEJM) has published interim results from the Phase III trial of Japanese drug major Takeda Pharma’s (TYO: 4502) Adzynma (apadamtase ...

Danish diabetes giant Novo Nordisk (NOV: N) today reported financial results for the first quarter of 2024, noting that sales ...

Sentynl Therapeutics, the USA-based wholly-owned subsidiary of Indian generics major Zydus Lifesciences (NYSE: ZYDUSLIFE), has announced the closing of the sale of Eiger BioPharmaceuticals’ (OTC: ...

The UK pharma sector is dynamic, supported by a government-led drive to make the UK a ‘Science Superpower’. 1 This steer from the government, alongside a strong patient advocacy landscape and ...

Osaka, Japan-based drugmaker Ono Pharmaceutical (TYO: 4528) has entered into a drug discovery collaboration agreement with ...